Saturday, January 17, 2026

Cronos Pays OSC $1.3 Million As Penalty For Accounting Fraud, Settles SEC Charges

A Capital Markets Tribunal panel yesterday accepted a settlement agreement between the Ontario Securities Commission and Cronos Group Inc (TSX: CRON) over accounting errors that resulted in two restatements of its interim financial statements.

The Canadian cannabis company paid a $1.3 million administrative penalty and an additional $40,000 towards the cost of the OSC’s investigation. Cronos has already paid such sums prior to the hearing.

Also part of the agreement, the firm will subject to a review of policies and processes, including Cronos’s compliance with obligations relating to internal controls over financial reporting, by an independent consultant acceptable to the Commission.

Cronos incorrectly recognized $7.6 million in revenue from three wholesale cannabis transactions in its Q1, Q2, and Q3 2019 interim financial statements. In its Q2 2021 interim financial statements, the company additionally inflated practically all of its US goodwill and a major percentage of its US intangible assets by a total of $234.9 million. As a result of these accounting errors, the firm revised its interim financial statements for the first, second, and third quarters of 2019, as well as its interim financial statements for the second quarter of 2021. Cronos revealed material flaws in internal control over financial reporting in both cases (ICFR).

William Hilson, Cronos’ former Chief Financial Officer and Chief Commercial Officer, was involved in one of the wholesale transactions in which Cronos overstated revenue by $3 million. In settling this dispute, Hilson agrees that he did not take the necessary steps to address Cronos’ management of revenue recognition difficulties for this transaction, and that his actions were detrimental to the public interest.

As part of the settlements, Hilson made a voluntary payment in the amount of $50,000 to the OSC plus $20,000 for the commission’s investigation costs. He will also be barred from serving as a director or officer of any reporting issuer for a year.

The OSC said it acknowledges the help extended by the US Securities and Exchange Commission, which also settled its own charges against Cronos and Hilson.

The settlement with SEC compels the firm to refrain from committing or causing any future violations of certain provisions of the United States federal securities laws. Cronos also committed to certain undertakings, including appointing a qualified independent consultant.

“We are pleased to have resolved these matters,” said CEO Mike Gorenstein. “Important steps have been taken to strengthen our internal controls, and we are committed to continuing this work.”

“As the industry continues to grow, it is imperative that investors receive accurate information about the financial performance of public cannabis companies to support informed investment decisions in this nascent sector,” said Jeff Kehoe, Director of Enforcement at the OSC. “The settlements announced today hold Cronos and Mr. Hilson accountable for their failures and serve as another excellent example of the OSC working across international borders to protect Ontario’s capital markets.

Cronos last traded at $4.23 on the TSX.


Information for this briefing was found via the OSC and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Recommended

NexGen Launches 42,000 Metre Drill Program At PCE While Expanding Mineralized Footprint

First Majestic Hits 2025 Guidance, Producing 31.1 Million Silver Equivalent Ounces, Increases Dividend

Related News

Cronos Group To Close Canadian Facility, Reports Q4 Net Loss Of $133.9 Million

Cronos Group (TSX: CRON) appears to be finally taking steps to address its absolute lack...

Tuesday, March 1, 2022, 08:48:47 AM

Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their...

Thursday, September 19, 2019, 09:23:17 AM

Cronos Group Delays Q3 2021 Results Again, Now Due To Be Filed By February 18

Cronos Group (TSX: CRON) (NASDAQ: CRON) by all accounts appears unable to get a firm...

Sunday, January 30, 2022, 02:37:09 PM

Cronos Confirms That It Has Received Expressions Of Interest, While Curaleaf Refuses To Comment

Cronos Group (TSX: CRON) has confirmed that it has received what amounts to “a number”...

Friday, July 7, 2023, 08:37:08 AM

Cronos Group Posts Fourth Straight Quarter Of Gross Losses In Q3 2020

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its third quarter financial results for...

Thursday, November 5, 2020, 08:19:42 AM